Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FB Financial CorpFBK · Entity 4279 | Director | May 22, 2026 | May 27, 2026 |
| HCA Healthcare, Inc.HCA · Entity 2929 | Director · Chairman | February 25, 2019 | February 27, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FB Financial Corp
Report date May 22, 2026 · Filed May 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,312 |
Reported balance
After 2026-05-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-22 · Grant · Acquired 1,329 · Balance 4,312 F1: Reflects an award of Restricted Stock Units (RSUs) granted pursuant to the issuer's Non-Employee Director Compensation Policy. The RSUs vest on April 30, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects an award of Restricted Stock Units (RSUs) granted pursuant to the issuer's Non-Employee Director Compensation Policy. The RSUs vest on April 30, 2027.
HCA Healthcare, Inc.
Report date February 25, 2019 · Filed February 27, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 881,823 |
Ending reported balance
After 2019-02-25 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-02-25 · Exercise / conversion · Acquired 7,475 · Balance 884,589 F1: Restricted stock units convert into common stock on a one-for-one basis. Row 2 · 2019-02-25 · Tax withholding · Disposed 2,766 · Balance 881,823 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-02-25 | Direct | 0 |
Reported balance
After 2019-02-25 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-02-25 · Exercise / conversion · Disposed 7,475 · Balance 0 F1: Restricted stock units convert into common stock on a one-for-one basis. F2: On February 25, 2016, the reporting person was granted 14,950 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. |
| Common StockSEC Table I · non-derivative | IndirectBy 2018 GRAT (Spouse, Trustee) | 200,000 |
Reported balance
Holding disclosure · report date 2019-02-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 200,000 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust (Spouse, Trustee) | 322,624 |
Reported balance
Holding disclosure · report date 2019-02-25 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 322,624 |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: On February 25, 2016, the reporting person was granted 14,950 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2026 Filed May 27, 2026 21:40 UTC | FB Financial Corp FBK · Entity 4279 | GrantCommon Stock | 1,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001216841-26-000003 · wk-form4_1779918053.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,312 F1 · security: Reflects an award of Restricted Stock Units (RSUs) granted pursuant to the issuer's Non-Employee Director Compensation Policy. The RSUs vest on April 30, 2027. Read SEC document |
| May 23, 2025 Filed May 28, 2025 16:19 UTC | FB Financial Corp FBK · Entity 4279 | GrantCommon Stock | 1,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001649749-25-000149 · wk-form4_1748449136.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,983 F1 · security: Reflects an award of Restricted Stock Units (RSUs) granted pursuant to the issuer's Non-Employee Director Compensation Policy. The RSUs vest on April 30, 2026. Read SEC document |
| May 24, 2024 Filed May 29, 2024 21:30 UTC | FB Financial Corp FBK · Entity 4279 | GrantCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001649749-24-000136 · wk-form4_1717018232.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,607 F1 · security: Reflects an award of Restricted Stock Units (RSUs) granted pursuant to the issuer's Non-Employee Director Compensation Policy. The RSUs vest on April 30, 2025. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:12 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 7,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014286 · doc4.xml · derivative · entry 5 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,475 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 14,950 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:12 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,766 | $143.26 | $396,257.16 |
DisclosureSEC source: 0001209191-19-014286 · doc4.xml · nonDerivative · entry 2 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 881,823 Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:12 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 7,475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-014286 · doc4.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 884,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:22 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 27,815 | $142.01 | $3,950,008.15 |
DisclosureSEC source: 0001209191-19-013236 · doc4.xml · nonDerivative · entry 2 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 877,114 Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:22 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 73,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013236 · doc4.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904,929 F1 · kind: On January 29, 2016, the reporting person was granted 60,020 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 17:37 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 7,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006555 · doc4.xml · nonDerivative · entry 2 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 831,555 Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 17:37 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 5,393 | $139.06 | $749,950.58 |
DisclosureSEC source: 0001209191-19-006555 · doc4.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 839,035 F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:24 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 7,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013633 · doc4.xml · derivative · entry 8 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,475 Underlying: Common Stock · 7,475 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 14,950 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:24 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 4,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013633 · doc4.xml · derivative · entry 7 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,547 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 9,093 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:24 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 4,449 | $100.84 | $448,637.16 |
DisclosureSEC source: 0001209191-18-013633 · doc4.xml · nonDerivative · entry 4 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,033,642 Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:24 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 12,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-013633 · doc4.xml · nonDerivative · entry 3 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,038,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:24 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 27,375 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-013633 · doc4.xml · derivative · entry 6 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,375 Underlying: Common Stock · 27,375 shares Expires 2024-02-05 F3 · balance_after: On February 5, 2014, the reporting person was granted 182,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 27,375 stock appreciation rights. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:24 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 49,109 | $100.54 | $4,937,418.86 |
DisclosureSEC source: 0001209191-18-013633 · doc4.xml · nonDerivative · entry 2 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,026,069 Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:24 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 124,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013633 · doc4.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,075,178 F1 · kind: On February 4, 2015, the reporting person was granted 62,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 640,070 | $0.00 Strike: $22.64 | $0.00 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 10 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 640,070 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.exercise_date: Two thirds of the option was vested upon grant on October 6, 2009, and one third of the option vested on November 17, 2009 F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 213,356 | $0.00 Strike: $17.65 | $0.00 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 9 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 213,356 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 213,365 | $0.00 Strike: $13.21 | $0.00 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 8 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 213,365 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 543,348 | $102.24 | $55,551,899.52 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 5 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950,378 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 640,070 | $22.64 | $14,492,144.91 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 4 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,493,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 213,356 | $17.65 | $3,765,114.67 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 3 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 853,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 213,365 | $13.21 | $2,818,018.24 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 2 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 251,570 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 7 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,570 Underlying: Common Stock · 251,570 shares Expires 2028-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| August 09, 2017 Filed Feb 2, 2018 19:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 21,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,935 Read SEC document |
| February 25, 2017 Filed Mar 1, 2017 00:21 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 4,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015495 · doc4.xml · derivative · entry 4 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,547 Underlying: Common Stock · 4,546 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 9,093 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2017 Filed Mar 1, 2017 00:21 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 1,782 | $87.07 | $155,158.74 |
DisclosureSEC source: 0001209191-17-015495 · doc4.xml · nonDerivative · entry 2 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,730 Read SEC document |
| February 25, 2017 Filed Mar 1, 2017 00:21 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 4,546 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-015495 · doc4.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 36,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-014517 · doc4.xml · derivative · entry 4 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,500 Underlying: Common Stock · 36,500 shares Expires 2024-02-05 F2 · balance_after: On February 5, 2014, the reporting person was granted 182,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 36,500 stock appreciation rights. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 32,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-014517 · doc4.xml · derivative · entry 3 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2023-02-06 F1 · balance_after: On February 6, 2013, the reporting person was granted 162,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 32,500 stock appreciation rights. Read SEC document |
| February 03, 2017 Filed Feb 24, 2017 23:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-014517 · doc4.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,966 Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 183,380 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007873 · doc4.xml · derivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,380 Underlying: Common Stock · 183,380 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.